GenVec Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-17

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

GenVec is a clinical-stage biopharmaceutical company utilizes its proprietary platform, adenovector technology. It's collaborations with National Institute of Health, US Navy and US Department of Agriculture to use its delivery platform to develop vaccines against HIV, influenza, malaria, and foot and mouth disease have established it as potential player in Vaccine market.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    GenVec is a clinical-stage biopharmaceutical company that specializes in using adenovector-based vectors to deliver gene-based therapies for the treatment of various cancers, including pancreatic, head and neck, and rectal cancer.The company's lead candidate, TNFerade, is in Phase II/III clinical trial for the treatment of pancreatic cancer.

    The key elements of the company's business strategy include: advancing the clinical development of its product candidate, TNFerade; continue application of its proprietary adenovector technology to develop new products and strengthening the company's financial and market position through its funded vaccine programs.

    The company's total revenues increased at a CAGR of 22.5% during 2002-2006, from $8.4 million to $18.9 million. This represents an absolute total growth of +$10.5 million for total revenues. The company's only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: genvec theratoh inc company history therapy tnferade profile swot questionaire

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.